Yahoo
NasdaqCM - Delayed Quote USD

BioCardia, Inc. (BCDA)

0.9026 +0.0526 (+6.19%)
At close: November 9 at 4:00:00 PM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0 0 58 477 1,352
Selling, General and Administrative Expenses
-3,198 -3,316 -3,672 -4,395 -4,419
Research and Development Expenses
-4,192 -4,962 -4,387 -7,726 -8,834
Operating Income/Expenses
-7,390 -8,278 -8,059 -12,121 -13,253
Total Operating Profit/Loss
-7,390 -8,278 -8,001 -11,644 -11,901
Other Income/Expense, Non-Operating
51 50 55 73 -6
Non-Operating Income/Expenses, Total
51 50 55 73 -6
Pretax Income
-7,339 -8,228 -7,946 -11,571 -11,907
Net Income from Continuing Operations
-7,339 -8,228 -7,946 -11,571 -11,907
Net Income after Extraordinary Items and Discontinued Operations
-7,339 -8,228 -7,946 -11,571 -11,907
Net Income after Non-Controlling/Minority Interests
-7,339 -8,228 -7,946 -11,571 -11,907
Net Income Available to Common Stockholders
-7,339 -8,228 -7,946 -11,571 -11,907
Diluted Net Income Available to Common Stockholders
-7,339 -8,228 -7,946 -11,571 -11,907
Basic EPS
-0.64 -1.23 -2.90 -8.19 -10.05
Diluted EPS
-0.64 -1.23 -2.90 -8.19 -10.05
Basic Weighted Average Shares Outstanding
9,970.6730 6,666.9430 2,743.8280 1,411.9980 1,181.3980
Diluted Weighted Average Shares Outstanding
9,970.6730 6,666.9430 2,743.8280 1,411.9980 1,181.3980
Income Statement, Supplemental
EBIT
-7,339 -8,228 -7,946 -11,571 -11,907
EBITDA
-7,326 -8,204 -7,879 -11,487 -11,825
Normalized EBITDA
-6,458 -7,293 -6,656 -10,126 -10,347
Normalized Income
-6,471 -7,317 -6,723 -10,210 -10,429
Total Unusual Items
868 911 1,223 1,361 1,478
Total Unusual Items Excluding Goodwill
868 911 1,223 1,361 1,478
Tax Effect of Unusual Items
0 0 0 0 0
Tax Rate, Calculated
0.00 0.00 0.00 0.00 0.00
12/31/2022 - 11/13/1996

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: